Has anyone been switched from ACTEMRA to TYENNE?

I just received this letter from the pharmacy department - anyone else get their medication changed?

We have important information to share with you regarding your tocilizumab (ACTEMRA) medication.

With your provider’s approval, your ACTEMRA prescription will be changed to TYENNE (tocilizumab-aazg). This change is occurring because TYENNE is now the preferred tocilizumab product at Kaiser Permanente.

TYENNE is a Food and Drug Administration (FDA) approved biosimilar of ACTEMRA. Both contain the same active medication, tocilizumab. Clinical studies have shown TYENNE to be as safe and effective as ACTEMRA and it works the same way in the body to manage your condition.

Do not use both ACTEMRA and TYENNE at the same time since they are the SAME medication, tocilizumab.

If you still have supply of ACTEMRA:
FIRST use up your supply of ACTEMRA THEN start using your new TYENNE prescription for your next scheduled tocilizumab dose.
Carefully read and follow the directions on the label of your new TYENNE prescription.

You should not expect any side effects or changes to your disease management when changing to TYENNE.

The Tyenne Autoinjector is slightly different than the Actemra ACTPen. Please read the “Instructions For Use” section of the Prescribing Information provided with TYENNE. You can also view an instructional video showing how to use TYENNE at: https://tyennehcp.com/get-started-on-tyenne.